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Preterm Birth during influenza 
season is associated with adverse 
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infants
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Objective: We investigated the relationship between influenza seasonality and outcome 
of very low birth weight infants (VLBWI) in a large observational cohort study of the 
German Neonatal Network.
Materials and methods: Within the observational period (July 2009 until December 
2014), five influenza seasons occurred (mean duration: 97 days, range: 48–131 days). 
We stratified VLBWI (n  =  10,187) according to date of birth into three categories: 
(1) before influenza season, (2) during influenza season, and (3) 3 months after the end 
of the respective season. Outcomes were assessed in univariate and logistic regression 
analyses. In a subgroup of infants (n = 1497), the number of respiratory infections during 
the first 24 months of life was assessed.
results: VLBWI born during influenza season carried a higher risk for clinical sepsis (31.0 
vs. 28.2%; p = 0.014) and periventricular leukomalacia (PVL, 3.7 vs. 2.5%, p = 0.004). 
In a multivariate logistic regression model, birth during influenza season was associated 
with PVL [odds ratio (OR) 1.47 (1.11–1.95), p =  0.007] and clinical sepsis [OR 1.13 
(1.01–1.27), p = 0.036], independent of known risk factors, i.e., gestational age, multiple 
birth, gender, and small for gestational age. The risk for bronchopulmonary dysplasia 
was not influenced by influenza seasonality. In the small subgroup with information on 
24 months follow-up (n = 1497), an increased incidence of common cold and bronchitis 
episodes was noted in infants born during influenza season.
conclusion: Our observational data indicate that preterm birth during influenza season 
is associated with PVL and sepsis. These are novel aspects that deserve further investi-
gations to address underlying causes and to include virus surveillance.
Keywords: very low birth weight infants, influenza, human, sepsis, outcome, periventricular leukomalacia, 
seasonality
TaBle 1 | influenza season.
influenza season Before  
season
season 3 months after 
season
October 12, 2009–January 31, 
2010 (days)
90a 111 90
December 13, 2010–April 10, 
2011 (days)
226 118 92
February 6, 2012–April 22,  
2012 (days)
211 76 92
December 10, 2012–April 21, 
2013 (days)
140 131 92
February 17, 2014–April 6,  
2014 (days)
210 + 178b 48 92
Total number of days 1055 484 458
Number of VLBWI 7552 3148 3537
aInfluenza season 2008/2009: December 1, 2008 until April 12, 2009.
bJuly 6, 2014–December 31, 2014, influenza season 2014/2015: January 5, 2015–April 
19, 2015.
Influenza season was defined according to data of the German sentinel surveillance 
system for influenza (Arbeitsgemeinschaft Influenza) at the Robert Koch Institute (12, 13).
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inTrODUcTiOn
Influenza infection can severely affect maternal health and 
pregnancy outcome (1). Outbreak reports on newly emerging 
influenza strains, e.g., 2009 H1N1 influenza A pandemic, clearly 
indicated that pregnant women are at an increased risk for 
hospitalization, acute respiratory distress syndrome, and death 
as compared to the general population (2). Influenza infection 
is known to trigger preterm birth, but the potential mechanism 
of influenza-mediated immune activation causing labor has not 
yet been clearly defined (3). Direct vertical transmission of the 
influenza virus to the fetus is rare but has been postulated to 
cause fetal demise or early neonatal death (4, 5). Hence, pregnant 
women constitute are target group for which specific preventive 
measures are required (6). Seasonal influenza epidemics are a 
driver of seasonality in gestation length (7). Seasonal influenza 
vaccines are effective interventions, as immunized mothers have 
a reduced risk to deliver prematurely during influenza season 
than unvaccinated mothers. In addition, maternal influenza 
immunization reduces the burden of febrile respiratory illness 
in young infants (8, 9). In Germany, seasonal influenza vaccina-
tion is recommended for all pregnant women from the second 
trimester and for pregnant women with underlying chronic 
disease from the first trimester since August 2010. Despite 
national recommendations for influenza vaccination of pregnant 
women, however, vaccination rates in European countries are 
low (≈10–26%) (10, 11). Influenza therefore remains a significant 
health-care problem during pregnancy with estimated incidence 
density rates of 1.8/100 person-weeks (11). It is yet unknown 
whether influenza seasonality affects the outcome of extremely 
preterm infants.
In the German Neonatal Network (GNN), we performed 
a large observational study including five influenza seasons to 
evaluate outcome data of very low birth weight infants (VLBWI) 
stratified to date of birth, i.e., before season, during season, or 
3  months after the end of season. Two hypotheses prompted 
our study: infants born during season have an increased risk for 
clinical sepsis during primary stay in hospital and for respiratory 
infections during infancy as compared to infants born before 
season.
MaTerials anD MeThODs
The GNN is a population-based cohort study of VLBWI 
enrolled in 54 neonatal intensive care units in Germany 
(GNN). The data for this observational investigation were 
collected between the July 13, 2009 (3  months after influenza 
season 2008/2009 had finished) until the December 31, 2014. 
The inclusion criteria were as follows: birth weight <1500  g 
and gestational age ≥22 + 0 and <37 + 0 weeks. Infants with 
lethal abnormalities were excluded. After written informed 
consent by the parents, the attending physicians enrolled the 
infants in the GNN. Then, a predefined clinical data set of 
220 parameters were recorded on case report forms and sent 
to the GNN coordinating center in Lübeck (see Parameters 
on Clinical Record Files for Infants Enrolled in the German 
Neonatal Network in Appendix). For those infants born in 
participating GNN centers but not enrolled in GNN, a basic 
data set including birth weight, gestational age, and major 
outcomes such as sepsis, bronchopulmonary dysplasia (BPD), 
and death was also collected. Reasons for non-participation in 
GNN included early death of infant, language difficulties, not 
approached for participation, and declined consent.
A physician specialized in neonatology or a study nurse moni-
tored the data quality by annual site visits.
study hypothesis
We hypothesized that infants born during influenza season have 
a higher likelihood to suffer from clinical sepsis (primary end-
point) than infants born before season. We additionally aimed 
to investigate whether influenza seasonality is associated with 
inflammation-mediated disorders, specifically periventricular 
leukomalacia (PVL) and BPD as secondary endpoints.
Definitions
Influenza Season
The duration of an influenza season was based on data 
of the German sentinel surveillance system for influenza 
(Arbeitsgemeinschaft Influenza) at the Robert Koch Institute. 
For each calendar week, the positivity rate was calculated, i.e., 
the proportion of sentinel samples that were tested positive for 
influenza virus by PCR in the National Reference Center for 
Influenza. The start of an influenza season was defined as the 
first of two consecutive weeks, in which the lower 95% confi-
dence limit of the positivity rate was at least 10%. The end of the 
epidemic period was determined by the week that precedes the 
first two consecutive weeks, in which the lower 95% confidence 
limit of the positivity rate drops below 10% [Table 1; (12, 13)]. 
Accordingly, “before influenza season” was defined as period 
from the first day after 3 months after the end of last season until 
the last day before the new season started. We also included a 
post-seasonal period of 3 months, defined as first day after the 
end of season until three full months after the end of season.
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clinical characteristics and Outcomes
The primary outcome Clinical sepsis was defined as sepsis with 
at least two signs (temperature >38°C or <36.5°C, tachycardia 
>200/min, new onset or increased frequency of bradycardias or 
apneas, hyperglycemia >140  mg/dl, base excess <−10  mval/l, 
changed skin color, increased oxygen requirements) and one 
laboratory sign (C-reactive protein >1 mg/dl, immature/neutro-
phil ratio >0.2, white blood cell count <5/nl, platelet count <100/
nl) and antibiotic treatment for ≥5days, but no proof of causative 
agent in the blood culture.
Gestational age was calculated from the best obstetric estimate 
based on early prenatal ultrasound and obstetric examination. 
Small for gestational age was defined as birth percentile <10 
according to gestational age.
Blood culture confirmed sepsis was defined as clinical sepsis 
with proof of causative agent in the blood culture.
Bronchopulmonary dysplasia was diagnosed when needing 
supplemental oxygen at 36 weeks of post-menstrual age (BPD).
Intracerebral hemorrhage (ICH) grades I–IV were diagnosed 
according to the ultrasound criteria of Papile (14) in line with 
a standardized protocol derived from the DEGUM (German 
Society for Ultrasound in Medicine).
Periventricular leukomalacia was defined as white matter brain 
injury, characterized by cystic degeneration of white matter near 
the lateral ventricles as diagnosed by ultrasound imaging which 
was applied in all participating centers.
Severe complication was defined as diagnosis of at least one of 
the following outcome measures: ICH grade III or intracerebral 
parenchymal hemorrhage, PVL, retinopathy of prematurity 
(ROP) requiring surgery, necrotizing enterocolitis, or focal 
intestinal perforation requiring surgery or need for ventriculo-
peritoneal shunting.
Death was defined as death occurring after admission to NICU 
within the primary stay in hospital.
Follow-up
German Neonatal Network infants are followed up regularly 
by the GNN study team at the age of 5  years with physi-
cal examinations and neurodevelopmental testings on-site. 
Neurodevelopmental testing included Movement Assessment 
Battery for Children-2 (M-ABC-2), Wechsler Preschool and 
Primary Scale of Intelligence-III (German version), visual test-
ing and audiometry.
For the 24-month follow-up, parents of surviving infants 
enrolled in GNN (birth year 2009–2011, n =  3946) received a 
voluntary questionnaire (according to KiGGS survey 1–2 years 
from Robert Koch Institute, Germany) (15). The KiGGS survey 
(German Health Interview and Examination Survey for Children 
and Adolescents) was conducted to collect representative data on 
the health status of children in Germany.
statistical analysis
In order to avoid selection bias, we analyzed the whole cohort 
of infants born in GNN centers and the subgroup of infants 
enrolled in GNN. We stratified VLBWI according to date of birth 
into three categories: (1) born before influenza season, (2) born 
during influenza season, and (3) born in the 3 months directly 
following the end of the season.
We modeled the probability 1 vs. 0 of suffering from a condi-
tion, i.e., clinical sepsis, in relation to influenza seasonality, i.e., 
exposure time which is defined by the annual reports on influenza 
surveillance data in Germany (Robert Koch Institute, Berlin). 
Data analysis was performed using the SPSS 22.0 data analysis 
package (Munich, Germany). Differences between infants born 
before, during, and 3 months after season were evaluated with 
Pearson chi-square test, T test, and Mann–Whitney U test. To 
determine potential associations between influenza seasonality 
and outcome of VLBWI, we conducted multiple logistic regres-
sion analyses with known confounding variables for outcomes, 
i.e., gestational age, gender, multiple birth, SGA, and exposure 
to antenatal steroids. Odds ratios (OR) and 95% confidence 
intervals (CI) were calculated. A p value of <0.05 was considered 
statistically significant. Missing data were not imputed.
ethics
The study was approved by the ethics committee of the University 
of Lübeck (08-022) and the local ethical committees at each 
study center. Written informed consent was obtained from at 
least one parent on behalf of the infant enrolled in the GNN.
resUlTs
influenza seasons
Within the observational period (July 13 until December 31, 
2014), five influenza seasons occurred (mean duration: 97 days, 
range: 48–131  days). About 10,187 VLBWI were enrolled in 
GNN, n = 5449 before influenza season, n = 2224 during influ-
enza season, and n = 2514 up to 3 months after the end of a season 
(Table 1). The maternal background in GNN enrolled infants was 
German (74.6%), other Europe/Russia (10.5%), Middle East/
Turkey (7.5%), and Asia or Africa (6.4%).
short-term Outcomes
Univariate Analysis
We found no remarkable differences in clinical characteristics 
within categories. A higher risk for clinical sepsis was noted in 
infants born during influenza season as compared to infants born 
before season (31.0 vs. 28.2%; p = 0.014; Table 2). Preterm birth 
during influenza season was also associated with a higher risk 
for PVL (3.7 vs. 2.5%, p = 0.004) as compared to infants born 
before season, while the risk for BPD was unaffected by influenza 
seasonality. We alternatively assessed date of birth according to 
month or quarterly period of the year (January–March, April–
June, July–September, and October–December) and link to PVL. 
We found no association between PVL and month of birth (mean 
3.1%, range 2.6–4.2%, p = 0.19) or quarterly period of the year 
(mean 3.1%, range 2.8–3.7%, p = 0.1).
Logistic Regression Analysis
We further assessed clinical sepsis and PVL in relation to 
influenza seasonality in a multivariate logistic regression model 
including known confounding variables, i.e., gestational age, 
TaBle 3 | Multivariate logistic regression analysis (infants enrolled in 
gnn).
Outcome clinical sepsis PVl
Affected infants/controls 2890/7044 297/9616
Gestational age/week OR 0.73 (0.71–0.74),  
p < 0.001
OR 0.79 (0.75–0.82), 
p < 0.001
Gender, female OR 0.9 (0.82–0.98),  
p < 0.025
OR 0.91 (0.72–1.15), 
p < 0.4
Multiple birth OR 0.89 (0.8–0.98),  
p < 0.022
OR 0.97 (0.76–1.25), 
p < 0.8
Antenatal steroids OR 0.8 (0.69–0.94), 
p < 0.005
OR 0.57 (0.41–0.78), 
p < 0.001
Small for gestational age OR 1.82 (1.6–2.06),  
p < 0.001
OR 0.9 (0.64–1.25), 
p < 0.5
Born influenza season OR 1.13 (1.01–1.27),  
p < 0.036
OR 1.47 (1.11–1.95), 
p < 0.007
Born 3 months after OR 1.05 (0.93–1.17),  
p < 0.4
OR 1.33 (1.0–1.76), 
p < 0.046
Data are given as odds ratios OR (95% confidence interval). Date of birth in relation to 
influenza seasonality was included as categorical variable.
ORs were calculated including date of birth before season as reference.
TaBle 2 | clinical characteristics of VlBWi according to timely relation with influenza season.
clinical characteristics all Before season influenza season 3 months after season p1 p2
Number of infants 10,187 5449 2224 2514
Gestational age (weeks), mean (SD) 28.7 (2.7) 28.7 (2.7) 28.7 (2.8) 28.7 (2.7) 0.9# 0.7*
Birth weight (g), mean (SD) 1059 (307) 1061 (307) 1055 (307) 1057 (307) 0.1# 0.3*
SGA (%) 18.5 18.4 20.1 17.3 0.05 0.08
Gender, female (%) 48.8 49.6 47.7 48.1 0.2 0.1
Multiple birth (%) 34.6 35.5 33 34.1 0.1 0.04
Clinical sepsis (%) 29.2 28.2 31 29.5 0.05 0.014
Blood culture proven sepsis (%) 12.1 12.1 12.5 12 0.9 0.6
BPD (O2 at 36 weeks, %) 12.8 12.3 13.4 13.4 0.2 0.2
Supplemental O2 at discharge 3.7 3.7 4 3.5 0.7 0.6
Intracerebral hemorrhage (%) 16.6 16.5 17.1 16.2 0.7 0.5
PVL (%) 3.0 2.5 3.7 3.4 0.009 0.004
Severe complication (%) 22.3 21.8 23.3 22.4 0.4 0.2
Death (%) 3.6 3.4 4.0 3.5 0.4 0.2
BPD (O2 at 36 weeks) or death (%) 15.1 14.6 16.0 15.5 0.2 0.1
p Values are derived from Pearson chi2 test or t-test (#) or Mann–Whitney U-test if indicated (*), p1 comparison of all three categories, p2 infants born during season vs. infants born 
before season.
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gender, multiple birth, SGA, and exposure to antenatal steroids. 
Birth during influenza season was associated with PVL [OR 1.47 
(1.11–1.95), p = 0.007] and clinical sepsis [OR 1.13 (1.01–1.27), 
p = 0.036]. Infants born 3 months after the end of season also 
had a higher predisposition to PVL, but not for clinical sepsis as 
compared to infants born before influenza season (Table 3). To 
account for cardiovascular compromise as potential risk factor 
for PVL, we included the need of inotropes in the first 24 h in 
our model. This proved to be significantly associated with PVL 
[OR 1.84 (1.34–2.52), p < 0.001] while birth during influenza 
season also remained a stable independent risk factor [OR 1.51 
(1.08–2.11), p = 0.017]. Likewise, clinical sepsis was associated 
with development of PVL [OR 1.74 (1.35–2.24), p  <  0.001] 
which did not affect the impact of birth during influenza season 
[OR 1.45 (1.1–1.93), p = 0.01]. The link between influenza sea-
sonality and PVL risk was not influenced by causes of preterm 
birth, i.e., amniotic infection [OR 1.1 (0.84–1.44), p = 0.5]; birth 
during influenza season [OR 1.47 (1.11–1.95), p =  0.008] or 
prolonged premature rupture of membranes [PPROM; OR 0.93 
(0.72–1.21), p =  0.6]; birth during influenza season [OR 1.48 
(1.11–1.97), p = 0.007].
Follow-up
In a small subgroup, if surviving infants born 2009–2011 
(n = 1497/3946, response rate by questionnaire: 37.9%) data on 
24-month follow-up were available. In this subgroup, 84.5% of 
responding parents had a German background, while 8% moth-
ers were born in other European countries and Russia, 4.5% in 
the Middle East/Turkey, and 2.6% Asia or Africa. VLBWI born 
during influenza season (n  =  395) were more often affected 
from upper airway infection (65 vs. 57 vs. 48%, p  =  0.001) 
than infants born before (n =  683) or 3  months after the end 
of season (n = 419), respectively. VLBWI born during influenza 
season also had a higher number of episodes of common cold as 
compared to infants born before season or 3 months thereafter 
(mean/median ± SE; 3.9/3 ± 0.1 vs. 3.5/3 ± 0.2 vs. 3.2/2 ± 0.1 
episodes, p = 0.006; Figure 1A) and for bronchitis (1.3/1 ± 0.1 vs. 
1.1/0 ±  0.1 vs. 1.1/0 ±  0.1 episodes, p =  0.04; Figure  1B). No 
significant differences were noted for atopic dermatitis between 
VLBWI born during season as compared to birth before or 
3 months after season (8.5 vs. 6.9 vs. 6.3%, p = 0.3).
DiscUssiOn
To the best of our knowledge, this is the first large scale popu-
lation-based data on the link between influenza seasonality and 
outcome of VLBWI. Preterm birth during influenza season was 
associated with a higher risk of PVL and clinical sepsis.
Influenza infection of the pregnant mother is a well-known 
risk factor for preterm delivery which proved to be independent 
of socio-economic factors (7). However, the outcome of VLBWI 
born during influenza season has received little attention so far, 
as most reports on outcome after antenatal influenza exposure 
restrict their data to short-term perinatal outcome, i.e., birth 
weight, gestational age, Apgar scores, and neonatal death (6, 16). 
We hypothesized that influenza seasonality affects the outcome of 
VLBWI. To address this aspect, we modeled the probability of a 
certain outcome and compared infants born and exposed during 
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FigUre 1 | risk for bronchitis and common cold in the first 24 months 
after discharge. The figure describes the mean numbers of episodes (bars, 
SEM as error bars, solid line as median) for (a) common cold and (B) bronchitis 
occurred during infancy. These data are based on parents’ responses to the 
KIGGS questionnaire (German Health Interview and Examination Survey for 
Children and Adolescents; www.kinder-jugend-gesundheit21.de, page 8, 
question 23) at 24 months of age. Data are described according to date of 
birth, i.e., before influenza season, during influenza season, and 3 months after 
the respective season had finished, respectively.
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influenza season to those born either before or 3 months after 
the end of influenza season. The latter category was included to 
account for the fact that maternal antibodies (after exposure dur-
ing season or previous vaccination) may have transferred in utero 
to those infants born up 3 months after the end of a season. Our 
approach is limited by the use of “potential influenza exposure 
(season)” as surrogate measure rather than definite virological 
surveillance and vaccination status in mothers of VLBWI and 
their offspring. Such surveillance has not yet been introduced 
into clinical routine in NICUs or experimental studies in large 
cohorts.
Very low birth weight infants frequently suffer from clinical 
sepsis, i.e., an incidence of 25–30% in the GNN cohort. The 
risk profile is characterized by gestational age, immaturity of 
systemic, and local immune responses and necessity of invasive 
procedures. The symptoms of clinical sepsis are non-specific, 
often indistinguishable between viral and bacterial illness. Due 
to the diagnostic challenge, antibiotic therapy is often started 
for suspected sepsis, but the cause of clinical deterioration often 
remains uncertain (17). In our study cohort, VLBWI born dur-
ing influenza season had an increased risk for clinical sepsis. In 
temperate climates, influenza is thought to exist at a low level 
of intensity throughout the year but exhibits a marked seasonal 
increase, typically during the winter months (18). Our observa-
tion may just reflect epidemiological characteristics of viral illness 
including influenza which drive exposure for mothers and their 
infants, as well as health-care workers (19). Other environmental 
factors may add to clinical sepsis risk during influenza season, 
particularly understaffing, respiratory illness of medical staff and 
overcrowding, which cannot be evaluated in our data set. Given 
the specific susceptibility of pregnant women during influenza 
season, the complex interplay of the mother’s immune response 
to influenza and fetal sensing of local microbial milieu might also 
increase the infection risk in the offspring. To address this aspect, 
we evaluated causes of preterm delivery but found no differences 
in relation to influenza seasonality. Infants born during season 
also had a higher predisposition to common cold and bronchitis 
in the first 24 months of life as compared to those infants born 
before or 3  months after season. This observation might be 
related to long-lasting reduced local immunity in infants born 
during influenza season. On the other hand, protective maternal 
antibody transfer to those infants born after season may play a 
role. It should be noted that the subgroup of infants with paren-
tal information on infections during infancy is small, 37.9% 
response rate to voluntary questionnaires. Following aspects may 
have contributed to the low response rate. First, the questionnaire 
contains many questions, hence motivation and time of parents 
to fill out the forms might be limited. Second, tracking parents is 
difficult for changing addresses. We contacted the German regis-
tration offices and send our questionnaires to the new addresses 
but still had a poor feedback. Third, language problems might 
account for our observation, as responding families had more 
often German background as compared to the whole cohort (84.5 
vs. 74.6%). Therefore, the validity of parents’ feedback is limited 
in our setting. However, our data are hypothesis generating and a 
useful starting point for an understanding of illness attributable 
to respiratory infection (20).
Our data imply an increased risk for classical cystic PVL in 
VLBWI infants born during influenza season. This is a novel 
aspect that deserves further investigation with specific attention 
to the multi-factorial pathogenesis of PVL. Patients with PVL 
often develop cerebral palsy, seizures, and vision or hearing 
deficits (21). There is general consensus that development of 
PVL may be caused by (1) decreased blood flow (ischemia) or 
oxygen supply (hypoxia) of the periventricular white matter 
6Härtel et al. Influenza Season and Outcome of VLBW Infants
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region and (2) damage to glial cells due to inflammation. These 
pathogenic conditions may occur ante-, peri-, and postnatally 
with varying underlying causes, including placenta dysfunction, 
fetal distress, and infections. As a result, a sequence of inflam-
matory responses is set off, including the release of cytokines 
and free radicals which are toxic to the developing brain (22). 
Influenza infection may cause neurological sequelae that are 
clinical correlates of hypoxic–ischemic and inflammatory signal-
ing cascades. For example, the Vascular Effects of Infection in 
Pediatric Stroke study demonstrated that upper airway infection 
transiently increased the risk of childhood ischemic stroke (23). 
In addition, acute encephalopathies with imaging signs of PVL 
were reported after influenza A infection in children during 
H1N1 2009 pandemic, as well as cases of (meningo)-encephalitis 
(24). Presumably, these adverse outcomes are immune mediated 
rather than a consequence of influenza virus directly entering 
the central nervous system (CNS). In a Japanese surveillance 
study over nine influenza seasons, only 10% of patients with 
neurological complications had PCR detection of influenza virus 
in the cerebrospinal fluid (25). To account for potential patho-
mechanisms of PVL in our cohort, we included surrogates for 
cardiovascular compromise (need for inotropes) or inflammation 
(clinical sepsis, preterm labor, amniotic infection, and PPROM) 
in regression models. Influenza seasonality, however, remained a 
stable independent risk factor of PVL. The same holds true when 
basic data sets of all VLBWI born in GNN centers (total n = 14,237 
VLBWI, n = 7552 born before influenza season, n = 3148 born 
during influenza season, n = 3537 born up to 3 months after the 
end of a season), including those who were not enrolled in GNN, 
were evaluated. In all VLBWI, preterm birth during influenza 
season was associated with a higher risk for PVL (3.8 vs. 2.7%, 
p = 0.005) as compared to infants born before season. Logistic 
regression analysis also revealed an association between birth 
during influenza season and PVL [OR 1.39 (1.1–1.75), p = 0.007]. 
Immunization status of the mother was unknown in our study. 
Theoretically, an effect of vaccination against influenza during 
pregnancy might be assumed. Further studies should take this 
point into regard.
It is current clinical standard to diagnose PVL in sequential 
head ultrasound exams in preterm infants but sensitivity is 
limited. Future studies need to include MRI technology in order 
to detect subtle white matter changes (punctuate lesions) and dif-
fuse white matter injury (diffuse excessive high signal intensity, 
DEHSI) (26).
Our observational data point to the role of prevention. As of 
yet, the benefit of influenza vaccinations of pregnant mothers and 
infants is not clear in the population of VLBWI. Particularly, the 
effectiveness of influenza vaccination in preterm infants remains 
uncertain (27). Previous data noted an adequate immunogenicity 
in 6- to 17-month-old extremely low birth weight infants after 
two influenza vaccine doses (28). Further vaccination studies 
along with experimental models are needed to address causal 
relationships between seasonal influenza and adverse outcome 
(29, 30). In order to protect highly vulnerable infants, influenza 
vaccination of medical staff should be enforced.
The major strengths of our study include a large population-
based cohort of VLBWI which is well phenotyped with quality 
assurance of data by on-site monitoring. Our study has limitations. 
The stratification in date of birth categories in relation to influ-
enza seasonality is based on epidemiological data from a national 
reference center rather proven evidence of influenza in VLBWI 
and their mothers. We defined birthday in relation to influenza 
seasonality as the main parameter for definition of the population 
at risk. Alternatively, we assessed date of birth according to month 
and found no association to PVL. Our observation is not a causal 
relationship and other respiratory viruses with seasonal patterns 
may have contributed to our finding. Virological surveillance in 
future population-based studies is needed and might provide data 
relevant to the development of age-specific prevention strategies.
In conclusion, our observational data indicate that preterm 
birth during influenza season is associated with adverse outcome. 
This is a novel aspect that deserves further investigations to 
address underlying causes and to include virus surveillance.
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aPPenDiX
a. Parameters on clinical record Files for 
infants enrolled in the german neonatal 
network
Birth Data of the Enrolled Infant
Initials, date of birth, inborn/outborn, gender, multiple birth, feto-
fetal transfusion syndrome and therapy, causes of premature birth 
(premature labor, chorioamnionitis, gestosis, HELLP syndrome, 
conspicuous CTG, abruption of placenta, anhydramnion, prema-
ture rupture of membranes >5 days/timepoint, onset before/with 
contractions, and anhydramnios), mode of birth (spontaneous, 
elective section, and emergency section), APGAR 5′, APGAR 
10′, pH of umbilical artery, base excess of umbilical artery, birth 
weight, length, circumference of head, body temperature at birth, 
gestational age in weeks + days, and congenital anomalies (life 
threatening, letal, and CRIBS score).
Resuscitation and Support within First 60 min of Life
Timepoint of resuscitation, sustained inflation, less invasive 
surfactant application (LISA), surfactant via endotracheal tube, 
intubation, bicarbonate infusion, application of volume, adrena-
lin, cardiopulmonary resuscitation, lactate levels within first 
60 min, lowest mean arterial pressure within first 24 h, and use of 
inotropes within first 24 h.
Maternal Data
Age, ethnicity, gravida, para, antenatal corticosteroids (type, 
completed cycle), tocolysis, cerclage, pessar, progesterone, admis-
sion to hospital >1 week before birth, and antenatal antibiotics 
(agents listed).
Individual Therapy of the Infant
Prophylactic drugs (vitamin K, teicoplanin/vancomycin, flu-
conazole, indomethacin, erythropoietin, and others), antibiotic 
therapy with specification of given antibiotics (agents listed), 
specification of inotrope therapy (dopamine, noradrenaline, 
dobutamine, adrenaline), analgetics (acetaminophen, morphine, 
thiopental, pentobarbital, midazolam, fentanyl, phenobarbital, 
chloral hydrate, piritramide, sufentanil, propofol, diazepam, 
and others), surfactant (including number of applications), 
mode of surfactant application, diuretics (furosemide, hydro-
chlorothiazide, and spironolactone), inhalative medicaments 
(salbutamol, NO, budesonide, ipratropium bromide, fluticasone, 
and others), transfusions (amount of red blood cell, platelet 
and fresh frozen plasma transfusions), caffeine, theophylline, 
doxapram, and other drugs, such as acetylcysteine, ambroxol, 
calcium gluconate, calcium glycerophosphate, calcium phos-
phate, dexamethasone, iron, glucose, hydrocortisone, ibuprofen, 
indomethacin, insulin, l-thyroxin, natrium gluconate, natrium 
glycerophosphate, bicarbonate, NaCl, omeprazole, phosphate, 
prednisolone, ranitidine, sildenafil, ursodeoxycholic acid, vita-
mins, zinc, and others, probiotics (Lactobacillus +  Bifidobacte
rium, Lactobacillus GG, E. coli, and others), vaccination (hexa 
polyvalent vaccines, pneumococcal vaccines, palivizumab, and 
rotavirus vaccination), stopping of application of medicaments 
due to adverse events, used central venous lines (central venous 
catheter, umbilical cord catheter, including material of catheter, 
silicone, and polyurethane) and possible complications, arterial 
catheter (umbilical artery catheter, peripheral artery catheter), 
complications of central access (infection, thrombosis), start of 
oral feeding, time to reach 150 ml/kg oral feeding in days, length 
of stay of intravenous catheter, and type of oral nutrition during 
hospital stay and at discharge (breast milk, donated breast milk, 
special preterm milk, industrial milk, and fortification of milk), 
begin and ending of oxygen supply, oxygen supply at discharge, 
and CPAP (CPAP, CPAP with IMV, HFO-CPAP, highflow nasal 
cannula), type of ventilation [conventional ventilation (SIMV, 
IMV, etc.), high frequency ventilation], time intervals of invasive 
ventilation, date of completed ventilation supply (inclusive 
CPAP), pulmonary interstitial emphysema, pneumothorax (dur-
ing invasive ventilation, non-invasive ventilation, spontaneous 
breathing), drainage of pneumothorax, sepsis (pathogen) within/
after 72 h of admission, pneumonia within/after 72 h of admis-
sion, necrotizing enterocolitis II/III, cranial ultrasound (grade of 
intracerebral hemorrhage I–IV, periventricular leukomalacia), 
hip dysplasia (grade Graf), retinopathy of prematurity (grades 
0–5) therapy of retinopathy of prematurity (bevacizumab, laser, 
and cryotherapy), result of screening for hearing loss, date and 
type of surgery (PDA, NEC, FIP, VP-shunt, herniotomy, and 
others), bronchopulmonary dysplasia (Walsh), date of discharge, 
weight, length, and head circumference at discharge, discharge 
home or to another facility, cause of death.
